Balyasny Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Balyasny Asset Management's AMGN Position: Q1 2026 in Review
Balyasny Asset Management reduced its Amgen (AMGN) stake by 42% in Q1 2026, selling an estimated $2.03M and leaving 7,980 shares worth $2.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1628.
Balyasny Asset Management first reported a position in AMGN in Q3 2014 and has held it in 35 quarters since. The position peaked at $96.1M in Q3 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Balyasny Asset Management held 7,980 shares of Amgen worth $2.81M as of Q1 2026.
- Balyasny Asset Management sold 5,688 Amgen shares in Q1 2026, an estimated $2.03M.
- Amgen made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1628 holding.
- Balyasny Asset Management first reported a position in Amgen in Q3 2014 and has held it in 35 quarters since.
- Balyasny Asset Management's Amgen position peaked at $96.1M in Q3 2024.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.